SANGUINE CORP
company.status.inactiveCIK 926287fmd_0BV8MYCDKEVBF0JSAEHRZCS05DManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2012, 10 periods
| Line item | FY2010 | FY2011 |
|---|---|---|
| Total revenues | 0 | 0 |
| Cost of revenue | 0 | 0 |
| Gross profit | 0 | 0 |
| Research and development | 0 | 0 |
| Selling, general and administrative | 0 | 0 |
| Total operating expenses | 0 | 1 |
| Operating income | (0) | (1) |
| Interest expense | 0 | 0 |
| Interest and investment income | 0 | 0 |
| Net income from continuing operations | (0) | (1) |
| Net income | (0) | (1) |